|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 16, 2018 ) Europe Stem Cell Market was worth $4.11 billion in 2016 and estimated to reach $7.92 billion by the end of 2021 with a CAGR of 14%. The allogeneic stem cell therapy is expected to command the largest share of the market in 2016. The market is expected to grow rapidly because of the extensive research and development which is being done. In the field of life sciences, one of the most promising markets at the moment is the global stem cell market and is expected to grow exponentially in the coming years as stem cells allow cost-effective treatment of many illnesses that currently have no or ineffective treatment.
View Full Report @ http://www.marketdataforecast.com/market-reports/europe-stem-cell-market-1086/
Regenerative medicine is perhaps the most important use of stem cells, and other important areas include oncology, haematology, orthopaedics, cardiology and neurology. Another widely found application is drug discovery and development. Stem cells are kind of a research tool, as their in vitro study would allow scientists to understand in depth about the role of various organs and the development of particular illnesses; stem cells may also possibly allow drug developers to test emerging therapies on diseased cells. Stem cells therapy has shown substantial potential to treat cancer successfully. Cancer stem cells which have been tested on animals have shown satisfactory results.
Some of the key drivers of the Europe stem cell market are improved funding from various government and private organizations for research and development for unmet medical needs, growing industry attention on stem cell research, and increasing global awareness about stem cell therapies. Development of cutting-edge genomic techniques for stem cell analysis, and increasing approvals for clinical trials of stem cell therapy are other factors that are propelling the growth of the market. While on the other hand, ethical issues are involved in the stem cells research and strict regulations to conduct trials on humans are some of the restraining factors. Also factors such as lack of required infrastructure and complications associated with the preservation of stem cell are limiting the growth of the stem cells market.
The stem cell market is segmented based on the treatment mode, cell types, applications, and technology. Treatment mode is segmented into allogeneic and autologous stem cell therapy. The cells type segment contains adult stem cells, induced pluripotent stem cells, human embryonic stem cells, and others. In the global stem cells market, the adult stem cells hold the highest share, while the market share of induced pluripotent stem cells is likely to grow in the next few years. The technology segment is divided into cell acquisition, cell production, cryopreservation and other sub-segments. On the basis of geography, the Europe market is analysed under various regions namely UK, Spain, Italy, Germany and France. As of now, North America region dominates the global stem cells market. Europe comes next. The European stem cells market is growing rapidly due to increase in the number of incidences of chronic diseases, and also research investments from government and private organizations.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/europe-stem-cell-market-1086/request-sample
Some of the major players in this market are Athersys, StemCells Inc., Cryo Cell International, Geron Corporation, Mesoblast Ltd., Aastrom Biosciences Inc., Celgene Corporation, Invitrogen and Cytori Therapeutics Inc.
Market Segmentation
1) By mode of treatment
Autologous
Allogeneic
2) By application
CNS
CVS
GIT
Regenerative Medicine
Musculoskeletal
Eye & Immune System Development
Blood Disorders
3) By technology
Cell Acquisition
Cell Production
Cryopreservation
Expansion
Sub-Culture
4) By type
Adult Stem Cells
Human Embryonic Cells
Pluripotent Stem Cell
Natural Rosette Cells
Inquire before Buying at http://www.marketdataforecast.com/market-reports/europe-stem-cell-market-1086/inquire
Reasons to buy Europe Stem Cell Market Research Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, color along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
